Abstract
ObjectivesAlmost 10% of ovarian cancer (OC) patients carry a somatic pathogenic variant (PV) in one of the ovarian cancer (OC) predisposition genes (e.g. BRCA1/2) and might respond to PARP inhibition....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have